DE3850325T2 - Monoklonalantikörper MZ gegen Ganglioside GD, MZ produzierende Zellen und MZ enthaltendes Agens. - Google Patents

Monoklonalantikörper MZ gegen Ganglioside GD, MZ produzierende Zellen und MZ enthaltendes Agens.

Info

Publication number
DE3850325T2
DE3850325T2 DE3850325T DE3850325T DE3850325T2 DE 3850325 T2 DE3850325 T2 DE 3850325T2 DE 3850325 T DE3850325 T DE 3850325T DE 3850325 T DE3850325 T DE 3850325T DE 3850325 T2 DE3850325 T2 DE 3850325T2
Authority
DE
Germany
Prior art keywords
monoclonal antibody
producing cells
containing agent
against ganglioside
ganglioside
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3850325T
Other languages
English (en)
Other versions
DE3850325D1 (de
Inventor
Shizuo Shimada
Daiji Iwata
Wakao Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Toatsu Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Publication of DE3850325D1 publication Critical patent/DE3850325D1/de
Application granted granted Critical
Publication of DE3850325T2 publication Critical patent/DE3850325T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE3850325T 1987-09-07 1988-09-07 Monoklonalantikörper MZ gegen Ganglioside GD, MZ produzierende Zellen und MZ enthaltendes Agens. Expired - Fee Related DE3850325T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62221862A JPH07116238B2 (ja) 1987-09-07 1987-09-07 抗ガングリオシドＧＤ１ａ単クローン性抗体ＭＺ、これを産生する細胞及びこれから成る試薬

Publications (2)

Publication Number Publication Date
DE3850325D1 DE3850325D1 (de) 1994-07-28
DE3850325T2 true DE3850325T2 (de) 1994-10-06

Family

ID=16773353

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3850325T Expired - Fee Related DE3850325T2 (de) 1987-09-07 1988-09-07 Monoklonalantikörper MZ gegen Ganglioside GD, MZ produzierende Zellen und MZ enthaltendes Agens.

Country Status (5)

Country Link
US (1) US5192662A (de)
EP (1) EP0307186B1 (de)
JP (1) JPH07116238B2 (de)
CA (1) CA1314246C (de)
DE (1) DE3850325T2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6762032B1 (en) * 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response

Also Published As

Publication number Publication date
EP0307186A2 (de) 1989-03-15
CA1314246C (en) 1993-03-09
US5192662A (en) 1993-03-09
EP0307186A3 (en) 1990-03-14
DE3850325D1 (de) 1994-07-28
JPH07116238B2 (ja) 1995-12-13
EP0307186B1 (de) 1994-06-22
JPS6467198A (en) 1989-03-13

Similar Documents

Publication Publication Date Title
DE3889795T3 (de) Polyesterfilm, enthaltend feine zellen.
DE69021456T2 (de) Monoklonale Antikörper gegen aktivierte endotheliale Zellen.
ATE111452T1 (de) Tetrahydronaphthalin- und indanderivate, deren herstellung und verwendung für pharmazeutische präparate.
DE3785994D1 (de) Antikoerper gegen interleukin-1.
DE3854502D1 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
IT8720894A0 (it) Agente antistatico.
NZ222981A (en) 2'-deoxy-2'2'-difluoronucleosides, antibody conjugates and pharmaceuticals containing the conjugates
DE69012601T2 (de) Gentherapie durch stützgewebebezügliche Zellen.
DE68919172D1 (de) MOSFET und dessen Herstellungsverfahren.
DE69428763T2 (de) Monoklonale Antikörper gegen Ganglioside und deren Verwendung in der spezifischen, aktiven Immuntherapie gegen bösartige Tumoren
FI883527A0 (fi) Elektrolytisk cell.
DE69600342T2 (de) Träger sowie Packung, die diesen enthält
DE3587714T2 (de) Menschliches alpha 2-Plasmin spezifischer monoklonaler Antikörper.
IL77990A (en) Monoclonal anti-alpha-amylase antibody,process for obtaining the same and pharmaceutical compositions containing the same
DE3850325D1 (de) Monoklonalantikörper MZ gegen Ganglioside GD, MZ produzierende Zellen und MZ enthaltendes Agens.
DE3888604T2 (de) Monoklonale Antikörper gegen Antithrombinbindende Substanz und seine Verwendungen.
TR26907A (tr) Yeni poliiodine bilesikleri, hazirlik prosesi ve bunlari iceren kontrast maddesi.
GB2236881B (en) Improved synapse cell employing dual gate transistor structure
DE3851855T2 (de) Gegen die Gamma-Kette des T-Zell-Rezeptors gerichteter monoklonaler Antikörper.
DE3785637D1 (de) Monoklonale antikoerper gegen menschliche mesotheliale zellen.
DE3670307D1 (de) Spezifische mycoplasma-membran-antigene und -antikoerper sowie deren klinische verwendungen.
DE68916322D1 (de) Zusammensetzung, die zweiwertiges Manganion enthält und Verfahren zu deren Herstellung.
BR8904681A (pt) Uma linha de celulas de hibridoma,mutantes,anticorpos,processos para a preparacao de uma linha de celulas e para a preparacao de anticorpos e processo e agente para comprovacao imunologica de atrazina
DE3786130D1 (de) Monoklonale antikoerper gegen oberflaechlichen ige-rezeptor, sowie hybrid-zellinien zu deren herstellung und verwendung.
PT79080A (de) Einschlussverbindungen von n,n-dimethyl-2-chlor-5-<3-methyl-2-(phenylimino)-4-thiazolin-4-yl>-phenylsulfonamid verfahren zu ihrer herstellung sowie pharmazeutische praeparate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee